Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Leucine and Troglitazone

supplement:

Leucine

Research Papers that Mention the Interaction

We recently reported that troglitazone , an insulin-sensitizing agent, inhibited l-type Ca2+ current (ICa, L ) more effectively in streptozotocin (STZ)-induced diabetic ventricular myocytes than in age-matched control myocytes.
Journal of cardiovascular pharmacology  •  2004  |  View Paper
Since troglitazone inhibits ICa, L more effectively in STZ‐induced diabetic ventricular myocytes, this agent may prevent cardiac dysfunction in diabetes.
Troglitazone , an insulin‐sensitizing agent shown to improve cardiac function in both experimental animals and patients with diabetes, inhibits voltage‐dependent L‐type Ca2+ currents (ICa, L ) in cardiac myocytes, which may underlie its cardioprotective effects.
British journal of pharmacology  •  2002  |  View Paper
[3H]Leucine uptake was also increased by mechanical strain (1.9-fold versus control, P <0.002), and this increase was inhibited by troglitazone and 15d-PGJ2 (troglitazone, −52% at 10 &mgr;mol/L, P <0.01; 15d-PGJ2, −70% at 10 &mgr;mol/L, P <0.005).
Circulation  •  2001  |  View Paper
Troglitazone effectively reduced the amplitude of ICa, L in a concentration-dependent manner.
Circulation  •  1999  |  View Paper